Medmal (Medical malpractice) | Insurance Insider US

Casualty and auto loss costs continue to rise due to inflation as we head into 2026.

The acquisition brought four collector vehicle MGAs to the carrier’s existing collector vehicle portfolio.

Quota share is less common in the medmal space, where layered and shared structures have been dominant.

California may not be the only state to see non-economic damage caps in medmal get challenged.

The chief executive said he doesn’t expect to see a price drop anytime soon.

There’s nothing medical about SAM claims.

Northeast Insurance said 55 claims were brought under the Child Victims Act.

The new chief executive has served on PI’s board since 2018, including as chair.

The division mostly places higher up the tower, where many insurers have taken action to address SAM losses.

Sexual abuse and molestation exclusions are starting to hold in higher layers of hospital towers this year.

The change reflects the insurers’ recent deal with ProAssurance.

Despite tort reform, physicians’ insurers are struggling with the same loss inflation challenges as other liability peers.

While the Fed is more concerned with jobs, other macroeconomic concerns trouble the industry.

High H1 reserve releases of $7.4bn were driven by the largest of carriers.

Despite mild headline CPI, some insurance-related items are heading in a worrying direction.

An industry veteran of 34 years, the executive is known for placing US healthcare business in London.

Rising inflation could raise claims severity but also increase investment income.

PL coverage is being stripped out of admitted, packaged policies and increasingly purchased in the E&S market.

The FTC granted early termination of the waiting period, leaving the acquisition on track to finish in early 2026.

The vote paves the way for the finalization of the deal in the first half of 2026.

Tariffs could drive up property loss costs, but the impact on other items has been muted.

The impact of SAM claims is reverberating through the tower and the broader marketplace beyond hospitals.

A deep-dive analysis shows LitFin is not the boogeyman this industry paints it out to be.

The Insurance Insider US news team runs you through this week’s key agency M&A.